LipoMASC liposome modification technology regulatory update

VLTS's PolyMASC Pharmaceuticals plc subsidiary (London, U.K.) received U.S. Patent No. 6,132,763 covering its LipoMASC technology that modifies the exterior of liposomes using polyethylene glycol (PEG...